Surgical & Medical Instruments & Apparatus Industry - SEC Form 4 Insider Trading Screener
Manufacturing Sector - Specialty Instruments - Surgical & Medical Instruments & Apparatus
100 results - 
- 
- 
- 
- 
- 
- 
- - - - - - | TC | cnt | 1d | 1w | 1m | 6m |
X |
Filing Date |
Trade Date |
Ticker |
Company | Insider Name | Insider Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2019-04-24 | SNWW | Sanuwave Health, Inc. | Stolarski Anthony Michael | Dir | P - Purchase | $0.08 | +2,475,000 | 6,199,626 | +66% | +$198,000 | ||||||
2019-04-24 | SNWW | Sanuwave Health, Inc. | Richardson Kevin A II | Dir | P - Purchase | $0.03 | +137,500 | 452,500 | +44% | +$4,593 | ||||||
| M | 2019-04-23 | PDEX | Pro Dex Inc | Cabillot Raymond E | Dir, 10% | S - Sale | $16.05 | -7,451 | 470,111 | -2% | -$119,551 | |||||
2019-04-23 | DXCM | Dexcom Inc | Doubleday Richard | EVP Chief Commercial Officer | S - Sale | $116.98 | -2,016 | 82,650 | -2% | -$235,838 | ||||||
2019-04-23 | DXCM | Dexcom Inc | Pacelli Steven Robert | EVP Strategy, Corporate Dev | S - Sale | $116.61 | -3,596 | 96,371 | -4% | -$419,329 | ||||||
2019-04-23 | XENT | Intersect Ent, Inc. | Stimson Susan P | Chief Strategy Officer | S - Sale | $30.00 | -2,663 | 43,115 | -6% | -$79,890 | ||||||
2019-04-22 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.66 | +5,914 | 18,421,692 | 0% | +$3,909 | ||||||
2019-04-18 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.65 | +2,000 | 18,415,778 | 0% | +$1,296 | ||||||
2019-04-17 | OFIX | Orthofix Medical Inc. | Mason Brad | CEO | S - Sale | $52.35 | -5,949 | 175,488 | -3% | -$311,444 | ||||||
2019-04-16 | INSP | Inspire Medical Systems, Inc. | Herbert Timothy P. | CEO, Pres | S - Sale | $54.97 | -15,000 | 199,974 | -7% | -$824,538 | ||||||
| D | 2019-04-16 | INSP | Inspire Medical Systems, Inc. | Buchholz Richard | CFO | S - Sale+OE | $56.05 | -4,000 | 4,750 | -46% | -$224,204 | |||||
| DM | 2019-04-16 | TCMD | Tactile Systems Technology Inc | Folkes Robert J. | COO | S - Sale+OE | $51.14 | -5,000 | 109,154 | -4% | -$255,700 | |||||
2019-04-16 | PDEX | Pro Dex Inc | Cabillot Raymond E | Dir, 10% | S - Sale | $16.00 | -200 | 477,562 | 0% | -$3,200 | ||||||
2019-04-17 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.66 | +10,500 | 18,413,778 | 0% | +$6,899 | ||||||
2019-04-15 | SIBN | Si-Bone, Inc. | Yerby Scott A | CTO | S - Sale | $16.94 | -10,349 | 206,328 | -5% | -$175,295 | ||||||
2019-04-15 | SIBN | Si-Bone, Inc. | Reiley Mark A | Dir | S - Sale | $16.95 | -10,000 | 532,624 | -2% | -$169,459 | ||||||
| D | 2019-04-15 | SIBN | Si-Bone, Inc. | Recupero Anthony J | Chief Commercial Officer | S - Sale+OE | $16.88 | -1,427 | 19,273 | -7% | -$24,089 | |||||
2019-04-15 | SIBN | Si-Bone, Inc. | Reckling W Carlton | CMO, VP, Medical Affairs | S - Sale | $16.59 | -151 | 10,049 | -1% | -$2,505 | ||||||
2019-04-15 | SIBN | Si-Bone, Inc. | Pisetsky Michael A | GC, Chief Compliance Officer | S - Sale | $16.59 | -241 | 18,073 | -1% | -$3,998 | ||||||
| D | 2018-04-15 | SIBN | Si-Bone, Inc. | Francis Laura | CFO | S - Sale+OE | $16.87 | -3,012 | 70,524 | -4% | -$50,827 | |||||
| A | 2019-03-12 | HJLI | Hancock Jaffe Laboratories, Inc. | Berman Robert Andrew | CEO | P - Purchase | $1.36 | +18,382 | 18,382 | New | +$25,000 | |||||
2019-04-15 | DXCM | Dexcom Inc | Foletta Mark G | Dir | S - Sale | $118.98 | -1,000 | 18,147 | -5% | -$118,977 | ||||||
2019-04-15 | TCMD | Tactile Systems Technology Inc | Rishe Bryan | SVP, Sales | S - Sale | $52.98 | -3,000 | 49,681 | -6% | -$158,940 | ||||||
| M | 2019-04-15 | BSX | Boston Scientific Corp | Sorenson John Bradley | SVP, Manuf, Sup Chn | S - Sale | $37.92 | -3,197 | 52,113 | -6% | -$121,223 | |||||
| D | 2019-04-15 | XENT | Intersect Ent, Inc. | Earnhardt Lisa D | Pres, CEO | S - Sale+OE | $28.43 | -29,588 | 448,165 | -6% | -$841,243 | |||||
2019-04-16 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.67 | +15,000 | 18,403,278 | 0% | +$10,065 | ||||||
| D | 2019-04-16 | SYK | Stryker Corp | Scannell Timothy J | Pres, COO | S - Sale+OE | $192.40 | -4,666 | 154,718 | -3% | -$897,727 | |||||
| D | 2019-04-15 | RMD | Resmed Inc | Douglas Robert Andrew | Pres, COO ResMed Inc. | S - Sale+OE | $102.29 | -4,285 | 197,654 | -2% | -$438,313 | |||||
2019-04-15 | DXCM | Dexcom Inc | Sayer Kevin R | Pres, CEO, COB | S - Sale | $118.91 | -6,000 | 306,100 | -2% | -$713,471 | ||||||
2019-04-15 | ATRC | Atricure, Inc. | Noznesky Justin J | SVP, Mktg, Business Develop | S - Sale | $27.64 | -12,569 | 104,068 | -11% | -$347,407 | ||||||
2019-04-15 | GNMK | Genmark Diagnostics, Inc. | Gleeson Michael | SVP, Corp. Accounts | S - Sale | $7.51 | -10,000 | 373,101 | -3% | -$75,100 | ||||||
| D | 2019-04-15 | BSX | Boston Scientific Corp | Nanavaty Maulik | SVP, Pres, Neuromodulation | S - Sale+OE | $37.81 | -3,039 | 254,469 | -1% | -$114,905 | |||||
2019-04-15 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.69 | +6,000 | 18,388,278 | 0% | +$4,122 | ||||||
2019-04-11 | PEN | Penumbra Inc | Elsesser Adam | COB, CEO, Pres | S - Sale | $141.58 | -8,000 | 1,113,982 | -1% | -$1,132,617 | ||||||
2019-04-11 | RMED | Ra Medical Systems, Inc. | Irwin Dean | See Remarks, 10% | S - Sale | $3.49 | -20,928 | 3,179,884 | -1% | -$73,039 | ||||||
| D | 2019-04-12 | ICUI | Icu Medical Inc/de | Swinney Robert S | Dir | S - Sale+OE | $231.43 | -229 | 18,972 | -1% | -$52,997 | |||||
2019-04-12 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.70 | +2,000 | 18,382,278 | 0% | +$1,392 | ||||||
2019-04-10 | DXCM | Dexcom Inc | Murphy Patrick Michael | SVP Legal Affairs | S - Sale | $115.05 | -400 | 36,260 | -1% | -$46,020 | ||||||
2019-04-10 | INSP | Inspire Medical Systems, Inc. | Nelson Marilyn C | Dir | S - Sale | $55.21 | -47,015 | 427,713 | -10% | -$2,595,698 | ||||||
| D | 2019-04-10 | XENT | Intersect Ent, Inc. | Stimson Susan P | Chief Strategy Officer | S - Sale+OE | $29.13 | -10,000 | 45,778 | -18% | -$291,318 | |||||
| A | 2019-04-10 | RVP | Retractable Technologies Inc | Shaw Thomas J | Presdient, CEO, 10% | P - Purchase | $0.68 | +2,100 | 14,080,278 | 0% | +$1,430 | |||||
| D | 2019-04-10 | NVCR | Novocure Ltd | Leung Gabriel | Dir | S - Sale+OE | $45.95 | -5,000 | 60,000 | -8% | -$229,750 | |||||
| D | 2019-04-10 | TFX | Teleflex Inc | Smith Benson | Dir | S - Sale+OE | $305.83 | -8,500 | 76,413 | -10% | -$2,599,540 | |||||
| D | 2019-04-08 | SILK | Silk Road Medical Inc | Wp X Finance, L.P. | 10% | S - Sale+OE | $20.00 | -900,000 | 12,199,629 | -7% | -$18,000,000 | |||||
| D | 2019-04-08 | SILK | Silk Road Medical Inc | Warburg Pincus & Co. | 10% | S - Sale+OE | $20.00 | -900,000 | 12,199,629 | -7% | -$18,000,000 | |||||
| D | 2019-04-10 | CERS | Cerus Corp | Green Kevin Dennis | CFO | S - Sale+OE | $6.51 | -2,786 | 79,273 | -3% | -$18,138 | |||||
| D | 2019-04-08 | ATRS | Antares Pharma, Inc. | Jacob Leonard S | Dir | S - Sale+OE | $3.00 | -92,078 | 239,892 | -28% | -$276,243 | |||||
2019-04-10 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.68 | +2,000 | 18,380,176 | 0% | +$1,362 | ||||||
| DM | 2019-04-08 | HAE | Haemonetics Corp | Goldstein Dan | VP, Corporate Controller | S - Sale+OE | $88.90 | -3,206 | 2,619 | -55% | -$285,003 | |||||
| D | 2019-04-08 | RMD | Resmed Inc | Farrell Michael J. | CEO | S - Sale+OE | $100.82 | -6,651 | 296,622 | -2% | -$670,554 | |||||
2019-04-09 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.69 | +2,000 | 18,378,176 | 0% | +$1,372 | ||||||
| D | 2019-04-08 | STIM | Neuronetics, Inc. | Thatcher Christopher | Pres, CEO | S - Sale+OE | $16.82 | -15,000 | 54,811 | -21% | -$252,300 | |||||
2019-04-05 | INSP | Inspire Medical Systems, Inc. | Ban Randy | SVP, Sales, Marketing | S - Sale | $51.70 | -10,000 | 20,974 | -32% | -$517,030 | ||||||
2019-04-05 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.68 | +12,000 | 18,376,178 | 0% | +$8,113 | ||||||
2019-04-05 | CMD | Cantel Medical Corp | Conway Lawrence | SVP | S - Sale | $67.00 | -800 | 3,417 | -19% | -$53,600 | ||||||
| D | 2019-04-03 | RMD | Resmed Inc | Pendarvis David | Chief Administrative Officer | S - Sale+OE | $105.21 | -4,457 | 118,002 | -4% | -$468,921 | |||||
| D | 2019-04-03 | TNDM | Tandem Diabetes Care Inc | Berger David B | EVP, GEN. COUNSEL, SECRETARY | S - Sale+OE | $62.60 | -2,000 | 1,965 | -50% | -$125,200 | |||||
| D | 2019-04-02 | PODD | Insulet Corp | Colleran David | SVP, Secretary, GC | S - Sale+OE | $94.89 | -7,395 | 30,433 | -20% | -$701,712 | |||||
2019-04-03 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.58 | +6,100 | 18,364,178 | 0% | +$3,529 | ||||||
2019-04-01 | PEN | Penumbra Inc | Kosaraju Sridhar | CFO, Head of Strategy | S - Sale | $143.45 | -5,000 | 266,966 | -2% | -$717,251 | ||||||
2019-04-01 | PEN | Penumbra Inc | Grewal Harpreet | Dir | S - Sale | $148.43 | -304 | 13,588 | -2% | -$45,123 | ||||||
2019-04-01 | PEN | Penumbra Inc | O'Rourke Bridget | Dir | S - Sale | $145.72 | -175 | 3,424 | -5% | -$25,501 | ||||||
| M | 2019-04-01 | INSP | Inspire Medical Systems, Inc. | Nelson Marilyn C | Dir | S - Sale | $51.66 | -152,985 | 479,669 | -24% | -$7,902,462 | |||||
| M | 2019-04-01 | INSP | Inspire Medical Systems, Inc. | Ban Randy | SVP, Sales, Marketing | S - Sale | $51.51 | -10,000 | 20,974 | -32% | -$515,118 | |||||
| D | 2019-04-01 | BAX | Baxter International Inc | Stroucken Albert P L | Dir | S - Sale+OE | $81.89 | -5,680 | 60,946 | -9% | -$465,135 | |||||
2019-04-01 | BAX | Baxter International Inc | Stallkamp Thomas T | Dir | S - Sale | $82.07 | -1,043 | 28,337 | -4% | -$85,599 | ||||||
| D | 2019-04-01 | BAX | Baxter International Inc | Hellman Peter S | Dir | S - Sale+OE | $81.89 | -5,680 | 23,654 | -19% | -$465,135 | |||||
| DM | 2019-04-01 | XENT | Intersect Ent, Inc. | Hilleman Jeryl L | CFO | S - Sale+OE | $32.18 | -51,200 | 31,884 | -62% | -$1,647,744 | |||||
2019-04-01 | XENT | Intersect Ent, Inc. | Binney Robert H Jr | Chief Commercial Officer | S - Sale | $31.98 | -3,495 | 11,897 | -23% | -$111,753 | ||||||
2019-04-02 | ARAY | Accuray Inc | Levine Joshua | Pres, CEO | S - Sale | $4.54 | -6,604 | 1,033,593 | -1% | -$29,982 | ||||||
| D | 2019-04-01 | OSUR | Orasure Technologies Inc | Tang Stephen S Phd | Pres, CEO | S - Sale+OE | $11.10 | -16,667 | 118,960 | -12% | -$185,015 | |||||
| DM | 2019-04-01 | RMD | Resmed Inc | McHale Richard | Pres, RC Business | S - Sale+OE | $105.00 | -27,846 | 23,404 | -54% | -$2,923,896 | |||||
| DM | 2019-04-01 | NVCR | Novocure Ltd | Ambrogi Michael J. | COO | S - Sale+OE | $47.34 | -49,891 | 185,674 | -21% | -$2,362,053 | |||||
2019-04-03 | ELGX | Endologix Inc /de/ | Onopchenko John | CEO, Dir | P - Purchase | $6.61 | +30,257 | 108,860 | +38% | +$199,999 | ||||||
2019-04-03 | ELGX | Endologix Inc /de/ | Mahboob Vaseem | CFO | P - Purchase | $6.61 | +15,128 | 89,320 | +20% | +$99,996 | ||||||
2019-04-03 | ELGX | Endologix Inc /de/ | Zenty III Thomas F | Dir | P - Purchase | $6.61 | +3,025 | 22,053 | +16% | +$19,995 | ||||||
2019-04-03 | ELGX | Endologix Inc /de/ | Neels Guido J | Dir | P - Purchase | $6.61 | +22,692 | 43,200 | +111% | +$149,994 | ||||||
2019-04-01 | SRDX | Surmodics Inc | Maharaj Gary R | Pres, CEO | S - Sale | $42.90 | -5,000 | 162,205 | -3% | -$214,498 | ||||||
2019-04-01 | RMD | Resmed Inc | Sandercock Brett | CFO | S - Sale | $104.96 | -3,000 | 85,390 | -3% | -$314,880 | ||||||
| D | 2019-04-01 | RMD | Resmed Inc | Hollingshead James | Pres, Sleep Business | S - Sale+OE | $104.96 | -1,600 | 79,657 | -2% | -$167,936 | |||||
2019-04-01 | DXCM | Dexcom Inc | Altman Steven R | Dir | S - Sale | $119.60 | -2,500 | 53,804 | -4% | -$298,999 | ||||||
| D | 2019-03-29 | MMSI | Merit Medical Systems Inc | Stanger Kent W | Dir | S - Sale+OE | $61.05 | -12,228 | 491,160 | -2% | -$746,507 | |||||
| D | 2019-03-29 | MMSI | Merit Medical Systems Inc | Miller Franklin J | Dir | S - Sale+OE | $61.38 | -5,000 | 32,231 | -13% | -$306,875 | |||||
| D | 2019-04-01 | BSX | Boston Scientific Corp | Pierce David A | EVP,Pres MedSurg | S - Sale+OE | $38.82 | -5,000 | 24,201 | -17% | -$194,100 | |||||
| D | 2019-03-29 | BAX | Baxter International Inc | Pleau Scott | SVP, Operations | S - Sale+OE | $80.00 | -9,710 | 20,076 | -33% | -$776,800 | |||||
2019-03-29 | SRDX | Surmodics Inc | Stich Joseph J. | VP, GM, IVD | S - Sale | $45.00 | -1,900 | 52,637 | -3% | -$85,500 | ||||||
| D | 2019-03-29 | MMM | 3M Co | Thulin Inge G | Exec COB | S - Sale+OE | $208.95 | -1,192 | 266,488 | 0% | -$249,067 | |||||
2019-03-29 | MMM | 3M Co | Thulin Inge G | Exec COB | S - Sale | $208.54 | -5,485 | 267,680 | -2% | -$1,143,855 | ||||||
2019-03-29 | MMM | 3M Co | Thulin Inge G | Exec COB | S - Sale | $208.27 | -6,034 | 273,165 | -2% | -$1,256,702 | ||||||
2019-03-29 | MMM | 3M Co | Thulin Inge G | Exec COB | S - Sale | $208.08 | -8,215 | 279,199 | -3% | -$1,709,390 | ||||||
2019-03-29 | MMM | 3M Co | Thulin Inge G | Exec COB | S - Sale | $207.78 | -5,863 | 289,043 | -2% | -$1,218,239 | ||||||
2019-03-28 | GMED | Globus Medical Inc | Huller Kelly | SVP, GC | S - Sale | $48.59 | -3,000 | 12,384 | -20% | -$145,770 | ||||||
2019-03-29 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.63 | +1,500 | 18,358,078 | 0% | +$947 | ||||||
| D | 2019-03-28 | TFX | Teleflex Inc | Klasko Stephen K. M.D. | Dir | S - Sale+OE | $301.68 | -200 | 389 | -34% | -$60,336 | |||||
| D | 2019-03-28 | TFX | Teleflex Inc | Smith Benson | Dir | S - Sale+OE | $300.15 | -8,500 | 76,413 | -10% | -$2,551,240 | |||||
2019-03-27 | CMD | Cantel Medical Corp | Capone Brian | SVP, Princ. Accounting Ofr | S - Sale | $66.09 | -70 | 3,674 | -2% | -$4,627 | ||||||
| DM | 2019-03-26 | MMSI | Merit Medical Systems Inc | Stanger Kent W | Dir | S - Sale+OE | $60.34 | -5,000 | 503,388 | -1% | -$301,683 | |||||
2019-03-27 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.68 | +32,500 | 18,356,578 | 0% | +$22,068 | ||||||
2019-03-27 | CVRS | Corindus Vascular Robotics, Inc. | Cannon Louis A | Dir | P - Purchase | $1.80 | +10,000 | 8,392,551 | 0% | +$18,000 | ||||||
2019-03-25 | VLRX | Valeritas Holdings Inc. | Armistice Capital, LLC | 10% | P - Purchase | $0.33 | +50,000 | 39,800,000 | 0% | +$16,530 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |